A gemcitabine based peptide conjugate with improved metabolic properties, dual mode of action and efficacy in animal models

2016 ◽  
Vol 61 ◽  
pp. S198-S199
Author(s):  
T. Karampelas ◽  
E. Skavatsou ◽  
O. Argyros ◽  
C. Tamvakopoulos
2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Bruce E. Tabashnik ◽  
Min Zhang ◽  
Jeffrey A. Fabrick ◽  
Yidong Wu ◽  
Meijing Gao ◽  
...  
Keyword(s):  

Pharmacology ◽  
2021 ◽  
pp. 1-13
Author(s):  
Catarina V. Jota Baptista ◽  
Ana I. Faustino-Rocha ◽  
Paula A. Oliveira

<b><i>Background:</i></b> The Nobel Prize of Physiology or Medicine (NPPM) has recognized the work of 222 scientists from different nationalities, from 1901 until 2020. From the total, 186 award researchers used animal models in their projects, and 21 were attributed to scientists and projects directly related to Pharmacology. In the most recent years, genetics is a dominant scientific area, while at the beginning of the 20th century, most of the studies were more related to anatomy, cytology, and physiology. <b><i>Summary:</i></b> Mammalian models were used in 144 NPPM projects, being rodents the most used group of species. Moreover, 92 researchers included domestic species in their work. The criteria used to choose the species, the number of animals used and the experimental protocol is always debatable and dependent on the scientific area of the study; however, the 3R’s principle can be applied to most scientific fields. Independently of the species, the animal model can be classified in different types and criteria, depending on their ecology, genetics, and mode of action. <b><i>Key-Messages:</i></b> The use of animal models in NPPM awarded projects, namely in Pharmacology, illustrates their importance, need and benefit to improve scientific knowledge and create solutions. In the future, with the contribute of technology, it might be possible to refine the use of animal models in pharmacology studies.


RSC Advances ◽  
2016 ◽  
Vol 6 (23) ◽  
pp. 19404-19412 ◽  
Author(s):  
Syusuke Egoshi ◽  
Yousuke Takaoka ◽  
Hiroaki Saito ◽  
Yuuki Nukadzuka ◽  
Kengo Hayashi ◽  
...  

A phytotoxin coronatine has a dual mode of action, triggering stomatal reopening through COI1–JAZ-dependent and independent pathways.


2016 ◽  
Vol 138 (39) ◽  
pp. 12975-12980 ◽  
Author(s):  
Katsuhiko Mitachi ◽  
Bilal A. Aleiwi ◽  
Christopher M. Schneider ◽  
Shajila Siricilla ◽  
Michio Kurosu

2006 ◽  
Vol 10 (S1) ◽  
pp. S54-S54 ◽  
Author(s):  
T.M. Tzschentke ◽  
J. Vry ◽  
T. Christoph ◽  
B. Kögel ◽  
K. Schiene ◽  
...  

Author(s):  
William Harnett ◽  
Margaret M. Harnett

There has been an alarming increase in the incidence of autoimmune and allergic diseases in Western countries in the past few decades. However, in countries endemic for parasitic helminth infections, such diseases remain relatively rare. Hence, it has been hypothesised that helminths may protect against the development of autoimmunity and allergy. This article reviews the evidence supporting this idea with respect to helminths of the phylum Nematoda (nematodes), considering data from human studies and animal models of inflammatory disease. The nature and mode of action of nematode-derived molecules with immunomodulatory properties are considered, and their therapeutic efficacy in models of autoimmunity and allergy described. The recent and future use of nematodes and their products in treating human disease are also discussed.


Sign in / Sign up

Export Citation Format

Share Document